N-Acetylglucosamine

This page covers all N-Acetylglucosamine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Killer cell lectin-like receptor subfamily B member 1A.

Targets

Killer cell lectin-like receptor subfamily B member 1A

Marketed (1)

• Acetylglucosamine · Metabolic
  Acetylglucosamine works by interacting with glycosaminoglycans in the body, influencing various biological processes.

Patent intelligence

• n acetylglucosamine patent landscape — aggregated cliff calendar, attackable patents, originator estates